Literature DB >> 12766135

Inflammation and insulin resistance.

Zachary T Bloomgarden1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12766135     DOI： 10.2337/diacare.26.6.1922

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  17 in total

Review 1.  Statin use in the metabolic syndrome.

Authors:  Justin B Lundbye; Paul D Thompson
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

Review 2.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

Review 3.  Inflammation in diabetic kidney disease.

Authors:  Patricia M García-García; María A Getino-Melián; Virginia Domínguez-Pimentel; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2014-08-15

Review 4.  Biomarkers in diabetic nephropathy: Present and future.

Authors:  Gemma Currie; Gerard McKay; Christian Delles
Journal:  World J Diabetes       Date:  2014-12-15

Review 5.  Mediators of inflammation in polycystic ovary syndrome in relation to adiposity.

Authors:  Thozhukat Sathyapalan; Stephen L Atkin
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

6.  Kidney proximal tubular epithelial-specific overexpression of netrin-1 suppresses inflammation and albuminuria through suppression of COX-2-mediated PGE2 production in streptozotocin-induced diabetic mice.

Authors:  Riyaz Mohamed; Calpurnia Jayakumar; Punithavathi V Ranganathan; Vadivel Ganapathy; Ganesan Ramesh
Journal:  Am J Pathol       Date:  2012-10-02       Impact factor: 4.307

Review 7.  Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mimi S Kim; Deborah P Merke
Journal:  Semin Reprod Med       Date:  2009-06-15       Impact factor: 1.303

8.  Impact of physical inactivity on adipose tissue low-grade inflammation in first-degree relatives of type 2 diabetic patients.

Authors:  Lise Højbjerre; Mette Paulli Sonne; Amra Ciric Alibegovic; Ninna Bo Nielsen; Flemming Dela; Allan Vaag; Jens Meldgaard Bruun; Bente Stallknecht
Journal:  Diabetes Care       Date:  2011-08-11       Impact factor: 19.112

9.  C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model.

Authors:  Hong-Min Kim; Eun Soo Lee; Bo Ra Lee; Dhananjay Yadav; You Mi Kim; Hyun-Jeong Ko; Kyu Sang Park; Eun Young Lee; Choon Hee Chung
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 10.  Challenges in diabetes management in Indonesia: a literature review.

Authors:  Pradana Soewondo; Alessandra Ferrario; Dicky Levenus Tahapary
Journal:  Global Health       Date:  2013-12-03       Impact factor: 4.185
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.